Why regulators may toss cold water on buzz over psychedelics
Drugs show promise as new treatment option for some psychiatric maladies, but experts see possible state, federal legal clash.
Interest in psychedelics is surging, fueled by growing research suggesting they have a place in treatment of conditions like depression and post-traumatic stress disorder. But regulatory challenges l…